Advertisement

Topics

New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures

19:00 EST 2 Jan 2018 | BioSpace

The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.

Original Article: New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures

NEXT ARTICLE

More From BioPortfolio on "New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...